|
Volumn 6, Issue 35, 2006, Pages 175-181
|
The impact of preventive HPV vaccination.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PAPILLOMA VIRUS VACCINE;
UNCLASSIFIED DRUG;
CHEMICAL STRUCTURE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
MALE;
REVIEW;
UTERINE CERVIX CARCINOMA IN SITU;
UTERINE CERVIX TUMOR;
VACCINATION;
VAGINA SMEAR;
VIROLOGY;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
CLINICAL TRIALS;
FEMALE;
HUMANS;
IMMUNOCOMPROMISED HOST;
MALE;
MODELS, MOLECULAR;
PAPILLOMAVIRUS VACCINES;
UTERINE CERVICAL NEOPLASMS;
VACCINATION;
VAGINAL SMEARS;
|
EID: 33947600814
PISSN: 15396509
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (12)
|
References (4)
|